Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
8
Bearish filings
93
Named actors
19
Disclosed $ (bull / bear)
$51.5M + 5 of unknown size / $43.9M + 1 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-16 | 5%+ holder (13G) — increased stake JPMORGAN CHASE & CO | increased its stake (13D/G amendment) | — | SEC ↗ |
| 2026-08-14 | 5%+ holder (13G) RTW INVESTMENTS, LP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-07-16 | 5%+ holder (13G) JPMORGAN CHASE & CO | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-07-02 | CEO, Managing Director Kapusta Matthew C | sold | $195K | SEC ↗ |
| 2026-07-02 | CEO, Managing Director Kapusta Matthew C | sold | $349K | SEC ↗ |
76 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-07-02 | CEO, Managing Director Kapusta Matthew C | sold | $409K | SEC ↗ |
| 2026-07-02 | Officer (via CITIGROUP GLOBAL MARKETS) Kapusta Matthew C | filed notice to sell | $952K | SEC ↗ |
| 2026-06-30 | Director Kaye Jack | sold | $191K | SEC ↗ |
| 2026-06-30 | Director Kaye Jack | sold | $792K | SEC ↗ |
| 2026-06-30 | Chief Medical Officer Abi-Saab Walid | sold | $465K | SEC ↗ |
| 2026-06-30 | Chief Medical Officer Abi-Saab Walid | sold | $928K | SEC ↗ |
| 2026-06-30 | Institution (13F) MAVERICK CAPITAL LTD | added to a position | $31.2M | — |
| 2026-06-30 | Director (via Citigroup Global Markets, Inc) Kaye Jack | filed notice to sell | $983K | SEC ↗ |
| 2026-06-30 | Chief Medical Officer (via Citigroup Global Markets, Inc) Abi-Saab Walid | filed notice to sell | $1.4M | SEC ↗ |
| 2026-06-26 | Chief Medical Officer Abi-Saab Walid | sold | $67K | SEC ↗ |
| 2026-06-26 | Chief Medical Officer (via Citigroup Global Markets, Inc) Abi-Saab Walid | filed notice to sell | $67K | SEC ↗ |
| 2026-06-25 | CEO, Managing Director Kapusta Matthew C | sold | $1.4M | SEC ↗ |
| 2026-06-25 | Officer (via CITIGROUP GLOBAL MARKETS) Kapusta Matthew C | filed notice to sell | $1.4M | SEC ↗ |
| 2026-06-24 | CEO, Managing Director Kapusta Matthew C | sold | $335K | SEC ↗ |
| 2026-06-24 | Officer (via CITIGROUP GLOBAL MARKETS) Kapusta Matthew C | filed notice to sell | $335K | SEC ↗ |
| 2026-06-18 | CEO, Managing Director Kapusta Matthew C | sold | $1.9M | SEC ↗ |
| 2026-06-18 | CEO, Managing Director Kapusta Matthew C | sold | $233K | SEC ↗ |
| 2026-06-18 | Officer (via CITIGROUP GLOBAL MARKETS) Kapusta Matthew C | filed notice to sell | $1.9M | SEC ↗ |
| 2026-06-17 | Director Kaye Jack | sold | $225K | SEC ↗ |
| 2026-06-17 | Director Balachandran Madhavan | sold | $249K | SEC ↗ |